Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room - Trial NCT06286241
Access comprehensive clinical trial information for NCT06286241 through Pure Global AI's free database. This phase not specified trial is sponsored by Siriraj Hospital and is currently Not yet recruiting. The study focuses on Multiple Myeloma. Target enrollment is 344 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Siriraj Hospital
Timeline & Enrollment
N/A
Mar 25, 2024
Jul 30, 2024
Primary Outcome
febrile neutropenia,Infection,duration of admission,progression free survival
Summary
The goal of this observational study is to comparison of the complications in multiple
 myeloma patients who received autologous stem cell transplantation between in HEPA-filtered
 room and non-HEPA-filtered room. The main questions it aims to answer are:
 
 - The incidence of febrile neutropenia, infection, and duration of hospital stay
 
 - 2-year progression free survival Participants will be collected the data of baseline
 diagnosis, treatment, treatment results and complications during admission and follow-up
 visits from hospital medical record.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06286241
Non-Device Trial